Top Stories

Policy Update: CBSA and Health Scholars Host State Rep. Shannon Bird

Learn More

Securisyn Medical Awarded Fourth Air Force Contract for Innovation

HIGHLANDS RANCH – November 12, 2019 – Securisyn Medical, LLC, dedicated to inspiring the world...

Learn More

Get weekly updates from Colorado’s leading source
for life sciences news and information.

Join Mailing List
Media Resources

Policy Update: CBSA and Health Scholars Host State Rep. Shannon Bird

Learn More

CBSA Annual Awards Dinner Celebrates the Life of Adam Rubenstein

CBSA celebrated the life of Adam Rubenstein at the 16th Annual Awards Dinner.

Learn More

Policy Update: Colorado Votes

Policy Update: Colorado Votes Colorado voters decided on two major ballot measures on Election Day 2019. Proposition DD asked voters to legalize sports betting in Colorado and create a 10 percent tax...

Learn More

Colorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner

Colorado BioScience Association Celebrates the Strength of State’s Life Sciences Ecosystem at Annual Awards Dinner Biodesix Named Company of the Year, Securisyn Medical Honored as Rising Star Denver,...

Learn More

Policy Update: Governor Jared Polis Releases Budget Proposal for FY 2020-21

Governor Jared Polis Releases Budget Proposal for FY 2020-21 Governor Jared Polis released his 2020-21 budget proposal on Friday, underscoring priorities that include expanding the state’s preschool p...

Learn More

Colorado BioScience Association Reveals New Website, Bold Brand

For Immediate Release: October 31, 2019 Colorado BioScience Association Reveals New Website, Bold Brand    Highlights Co-Opportunity, Colorado’s Collaborative, Pro-Innovation Environmen...

Learn More

CBSA Co-opportunity Means…

Health innovations from Colorado make a global impact.

Learn More

Weekly Policy Update: CBSA Co-Hosts Aurora Facility Tour for State Senator Rhonda Fields

This week CBSA partnered with CSL Behring to host state Senator Rhonda Fields for a tour of the CSL Plasma Collection Center in Aurora. On the tour, the collection center managers were able to show Se...

Learn More

Colorado BioScience Association Welcomes New Appointees to the Board of Directors

Colorado BioScience Association Welcomes New Appointees to the Board of Directors For Immediate Release: October 25, 2019 Colorado BioScience Association Welcomes New Appointees to the Board of Direct...

Learn More

Weekly Policy Update: CBSA Partners with LivaNova to host Rep. Brianna Titone

This week CBSA partnered with LivaNova to host state Rep. Brianna Titone for a tour and employee town hall at the company’s Arvada facility. It was a great opportunity to showcase the devices that are...

Learn More

Weekly Policy Update: State Releases Draft Proposal for Public Health Insurance Option

  On Monday, the Colorado Division of Insurance and the Department of Health Care Policy and Financing released a draft report on the development of the state’s plan for a public health insurance...

Learn More

Weekly Policy Update: CBSA Urges Congress to Reject Proposals that Adopt Foreign Price Controls

CBSA is committed to ensuring patients have access to the treatments they need. We appreciate the bipartisan efforts underway by the Trump Administration and Congress to provide patients relief from h...

Learn More

Weekly Policy Update: House Speaker Nancy Pelosi Releases Proposal on Prescription Drug Pricing

On September 19, House Speaker Nancy Pelosi released a long-anticipated proposal intended to reduce prescription drug prices. H.R. 3, the Lower Drug Costs Now Act of 2019, includes the following provi...

Learn More

Weekly Policy Update: Zimmer Biomet Spine Hosts Congressman Ed Perlmutter at Westminster Facility

At the end of August, Congressman Ed Perlmutter (CO-07) visited Zimmer Biomet Spine in Westminster to tour the medical education training facilities, biomechanics labs, and manufacturing area. Followi...

Learn More

2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail

Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...

Learn More

Weekly Policy Update: CBSA Hosts Congressman Jason Crow (CO-06)

  This month CBSA partnered with Fitzsimons Innovation Community, Gates Biomanufacturing Facility and Sharklet Technologies to host Congressman Jason Crow (CO-06) for a campus tour and roundtable...

Learn More

Weekly Policy Update: CBSA Meets with Executive Director of OEDIT

  This week CBSA President & CEO Jennifer Jones Paton and Vice President Emily Roberts met with Betsy Markey, Executive Director of the Office of Economic Development and International Trade...

Learn More

Weekly Policy Update: Take Action! Join a New Letter Urging Congress to Prioritize Repeal of the Medical Device Tax

Last week we asked the Colorado bioscience community to take action and urge our Members of Congress to support permanent repeal of the medical device excise tax. The tax is a threat to medical innova...

Learn More

Weekly Policy Update: End the Device Tax

The Colorado BioScience Association strongly opposes the medical device tax, a 2.3% excise tax on the sale of certain medical technology that was enacted as part of the Affordable Care Act. Since its...

Learn More

Weekly Policy Update: HHS and FDA Announce Plan to Allow Importation of Prescription Drugs

This week the Department of Health and Human Services (HHS) and the Food and Drug Administration (FDA) released a plan that describes the steps they will take to allow importation of certain drugs fro...

Learn More

Weekly Policy Update: Senate Finance Committee Advances Drug Pricing Package

On Thursday, the Senate Finance Committee advanced a major legislative package that includes substantial changes to Medicare and Medicaid drug reimbursement. The bill, the Prescription Drug Pricing Re...

Learn More

2019 Rocky Mountain Life Science Investor and Partnering Conference Opens in Vail

Colorado BioScience Association connects health innovators to investors during biennial event Vail, Colo. – Colorado BioScience Association (CBSA) welcomes investors and strategic partners from across...

Learn More

Weekly Policy Update: We Work For Health Summit—CBSA Urges Federal Lawmakers to Promote Medical Innovation and Protect Patient Access

This week CBSA vice president Emily Roberts joined other state advocates in Washington, DC for the We Work For Health Summit. During the two-day event, advocates met with their respective delegation t...

Learn More

Viewray to Expand to Denver, Adding 274 Jobs

Viewray, Inc., an Ohio-based medical technology company that provides high-level MRI-guided radiation technology is expanding its operations in the metro Denver area and will be hiring 274 people over...

Learn More

Weekly Policy Update: Trump Administration Pulls Rebate Rule

Last week the Trump Administration withdrew their proposed rebate rule that would have required manufacturer rebates to be passed through to patients in Part D and other government programs. The propo...

Learn More

Weekly Policy Update: Drug Pricing Bills Pass Key Senate Committees

Before the holiday, both the Senate Judiciary Committee and the Senate Health, Education, Labor, and Pensions (HELP) Committee advanced legislative packages aimed at lowering prescription drug prices....

Learn More

Weekly Policy Update: New Economic Forecast Indicates Increase in Expected Revenue Above the TABOR Cap

The Colorado Legislative Council released their updated budget and economic forecast this week, which showed a strong economy in the state of Colorado, an increase in expected revenue, and high wage g...

Learn More

New State-of-the-Art Facility Increases Agilent's Capacity to Produce Nucleic Acid-Based Therapeutics

New facility in Frederick, Colorado, to produce high-quality molecules with the potential to treat cancer and other diseases SANTA CLARA, Calif., June 18, 2019 Agilent Technologies Inc. (NYSE: A) toda...

Learn More

Pfizer to buy Colorado's Array BioPharma in deal worth $11.4 billion

Pharmaceutical giant Pfizer Inc. is delving deeper into cancer research with a roughly $11.4 billion deal for Array BioPharma Inc., a Colorado drug developer that has seen its shares soar since announ...

Learn More

Weekly Policy Update: CBSA Submits Comment Letter to Senate Finance Committee’s Health Task Force Urging Repeal of the Medical Device Excise Tax

Last month, leaders of the Senate Finance Committee announced the formation of several bipartisan task forces to examine 42 temporary tax provisions that expired or will expire between December 31, 20...

Learn More

CutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals

WOBURN, Mass. (Jun. 12, 2019) – CutisPharma, Inc. announced today its acquisition of Silvergate Pharmaceuticals, Inc. and the unveiling of its new corporate brand for the unified company: Azurity Phar...

Learn More

Weekly Policy Update: CBSA Attends the 2019 BIO International Convention

Last week CBSA President and CEO Jennifer Jones Paton and Vice President Emily Roberts attended the 2019 BIO International Convention in Philadelphia. The event brings together over 16,000 attendees f...

Learn More

Colorado BioScience Association Celebrates State’s Collaborative Nature

New Magazine Offers In-Depth Financing Data and Insights on Medical Device and Drug Approvals DENVER – Colorado BioScience Association (CBSA) today launched the new issue of its annual magazine, BioSc...

Learn More

Improving the Reimbursement Landscape for Medical Technology Innovators

CBSA continues to work with Congress and federal policymakers to improve the reimbursement landscape for medical technology innovators. Even when groundbreaking and innovative technologies meet FDA’s...

Learn More

27 Companies Share 6.1 Million Dollars in 2019 Advanced Industries Accelerator Grants

Colorado BioScience Association congratulates the 27 companies recently recognized as valuable investments for the entire state by the Office of Economic Development and International Trade’s (OEDIT)...

Learn More

CMS Rolls Back Harmful Proposals in Medicare Part D

Last Thursday CMS finalized a rule on Modernizing Part D and Medicare Advantage to Lower Drug Prices and Reduce Out-of-Pocket Expenses, which included a number of significant changes to the proposed r...

Learn More

Weekly Policy Update: CMS Proposed Rule is a Step Forward for the Coverage of Breakthrough Technologies

In late April, the Centers for Medicare and Medicaid Services (CMS) publicly released its FY 2020 Inpatient Prospective Payment System (IPPS) Proposed Rule. The rule is a critical step forward for cov...

Learn More

Weekly Policy Update: The Final Tally - 2019 Legislative Session Comes to a Close

CBSA has worked hard this session to advocate on behalf of the industry. We’ve worked with our members and partners to advance proposals that promote patient safety, protect patient access, and enhanc...

Learn More

Weekly Policy Update: One Week Left - What Will Make It Across the Finish Line

With just over a week left in the 2019 legislative session, there are hundreds of bills left to debate and Democrats are scrambling to get their remaining priorities across the finish line. Here are s...

Learn More

CBSA Opposes Drug Importation and Continues to Advocate for Safe Policy to Reduce Patient Costs

Last week CBSA testified in the House Health and Insurance Committee in opposition to Senate Bill 005 - Import Prescription Drugs From Canada, which would require the Department of Health Care Policy...

Learn More

Weekly Policy Update: CBSA Applauds Introduction of House Bill to Permanently Repeal Medical Device Excise Tax

This week bipartisan legislation was introduced in the U.S. House of Representatives to permanently repeal the medical device excise tax. CBSA applauds the introduction of H.R. 2207, Protect Medical I...

Learn More

Weekly Policy Update: Drug Pricing Transparency Bill Introduced in Colorado, Plus CBSA Advocates in DC

This week CBSA testified in the House Health and Insurance Committee in opposition to House Bill 1296 – Prescription Drug Cost Reduction Measures. The bill requires health insurers, prescription drug...

Learn More

CBSA and BIO Honor Colorado Congressional Leaders as Innovators in Biotechnology

Senator Michael Bennet, Congresswoman Diana DeGette Recognized as Champions of Life Science Washington, D.C. (April 4, 2019) – Colorado BioScience Association and Biotechnology Innovation Organization...

Learn More

Weekly Policy Update: CBSA Raises Concerns about Importing Drugs From Canada, Plus A Full Review of this Month In Policy

This week President & CEO Jennifer Jones Paton spoke with 630 KHOW’s Krista Kafer about CBSA’s opposition to Senate Bill 5, which would create a Canadian drug importation program in Colorado. Thro...

Learn More

Weekly Policy Update: Colorado State Budget and Forecast, Plus CBSA Voices Concerns on Drug Pricing Legislation

Last week the non-partisan Legislative Council published the forecast for the economy and state government revenue through FY 2019-20. The forecast showed that while the economy will continue to grow...

Learn More

Weekly Policy Update: Family Medical Leave Insurance Program and the President's Proposed Budget

On Wednesday Senate Bill 188, FAMLI Family Medical Leave Insurance Program, was heard and passed out of the Senate Committee on Business, Labor & Technology. The bill would create a state-run fami...

Learn More

Weekly Policy Update: Colorado BioScience Association’s Annual Day at the Capitol

This week CBSA held our annual Day at the Capitol event, bringing healthcare innovators to the state Capitol to highlight the discoveries and advancements taking place in Colorado to improve the healt...

Learn More

Colorado BioScience Association Explores New Possibilities for Medtech at Annual Symposium

Medical device industry leaders to focus on blockchain technology, M&A trends and federal policy DENVER – Colorado BioScience Association (CBSA) focuses on the opportunities offered by blockchain...

Learn More

Weekly Policy Update: AdvaMed Fly-In and the Monthly Report

This month CBSA Vice President Emily Roberts met with Members of the Colorado Congressional delegation as part of the AdvaMed State Medical Technology Alliance (SMTA) Fly-In. This event brings togethe...

Learn More

Weekly Policy Update: CBSA and LivaNova Partner to Host Senator Cory Gardner

This week CBSA partnered with LivaNova to host Senator Cory Gardner at LivaNova’s Arvada facility. The event included a brief meeting with the Senator and his staff, followed by a tour of the facility...

Learn More

Colorado BioScience Association connects lawmakers to patient-focused innovators at Capitol event

New results highlight success of state-funded grant program for early-stage life science companies DENVER – Colorado BioScience Association (CBSA) brings healthcare innovators to the state Capitol to...

Learn More

Weekly Policy Update: CBSA Opposes House Bill 1131, Prescription Drug Cost Education

This week, CBSA attended a stakeholder meeting on House Bill 1131, Prescription Drug Cost Education. As the bill is currently written; it requires a drug manufacturer, wholesaler, agent or an employee...

Learn More

Weekly Policy Update: Trump Administration Takes Step to Encourage Direct Discounts to Patients

On Tuesday President Trump gave his State of the Union address, in which he described the need to rein in health care costs as a major priority. The President also laid out an ambitious health care ag...

Learn More

Colorado BioScience Association Appoints Emily Roberts as New Vice President

Roberts to Oversee Policy and Communications at Life Science Organization DENVER – Colorado BioScience Association (CBSA) announces the appointment of Emily Roberts to vice president. Roberts takes ov...

Learn More

Weekly Policy Update: Prescription Drug Importation and CBSA’s Day at the Capitol

Yesterday the Colorado BioScience Association testified in opposition to Senate Bill 005, which tasks the department of health care policy and financing to design a program to import prescription phar...

Learn More

Weekly Policy Update: Colorado Bioscience Championed in Denver Business Journal

Colorado BioScience Association is focused on increasing our companies’ access to capital and highlighting the innovative work coming out of our state. Our team recently collaborated with the Denver B...

Learn More

Weekly Policy Update: Importing Drugs and the Governor's Budget

Last week CBSA took an opposition position to Senate Bill 005 – Import Prescription Drugs from Canada. As a reminder this bill would create the "Colorado Wholesale Importation of Prescription Drugs Ac...

Learn More

Weekly Policy Update: New General Assembly, Inauguration, and Bill Introductions

This marks the first full week of the 72nd First Regular Session of the Colorado General Assembly. It was a busy week with bill introductions, Governor Polis’ Inauguration and the State of the State (...

Learn More

Weekly Policy Update: CBSA’s Policy Priorities for 2019

Today, January 4, 2019 marks the first of 120 days of the 72nd General Assembly. CBSA looks forward to advocating on behalf of our members, industry and the patients we serve. We also look forward to...

Learn More

Colorado Bioscience Companies Raised $1 Billion in 2018

International Investors Contributed to the State’s Largest Financings DENVER – Colorado’s life science sector raised $1 billion in 2018, entering a second year of fundraising exceeding the $1 billion...

Learn More

Weekly Policy Update: More Medical Device Tax News and the 2018 Farm Bill

TheHouse Ways and Means Committee this week released a new extenders package which included a 5-year extension on the medical device excise tax moratorium. The 2.3% levy on the sale of prescribed medi...

Learn More

Weekly Policy Update: Protecting Medicare Beneficiaries and Medical Device Tax Work

A recent proposal by the Centers for Medicare & Medicaid Services (CMS) would implement an unprecedented Part B demo that could harm Medicare beneficiaries. We believe this would alter the entire...

Learn More

Weekly Policy Update: November Recap

The November Focus newsletter was published this afternoon with Jennifer’s recap of the full month in policy news. Topics covered include: November Elections At the federal level Republicans have reta...

Learn More

Weekly Policy Update: Leadership Elections in the Colorado General Assembly

With final certification of ballots by the Secretary of State the final tally for the Democrats in the House is 41, leaving Republicans with only 24 seats. Democrats in the Senate hold the majority by...

Learn More

Weekly Policy Update: Election Report

Federal In the Senate, Republicans have retained their majority. The Republicans control 51 seats, the Democrats 44. In the House, Democrats will take the majority by more than 25 seats. Democrats con...

Learn More

Colorado BioScience Association Ignites the Future at Fifteenth Annual Awards Dinner

miRagen Named Company of the Year, Inscripta Honored as Rising Star DENVER – Colorado’s life science sector gathered on November 8 at the Hyatt Regency in Denver to honor the bioscience companies, lea...

Learn More

Colorado BioScience Association Appoints Jennifer Jones Paton as New President and Chief Executive Officer

Jones Paton Promoted to Lead Life Science Organization After Broad Search DENVER – Colorado BioScience Association (CBSA) announces the promotion of Jennifer Jones Paton to president and chief executi...

Learn More

Weekly Policy Update: An October Recap

This week, the October Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. Some of the featured content includes: GET OUT...

Learn More

Weekly Policy Update: Get Out and Vote!

We know elections are important and that they shape the outcomes of our State, the economy and ultimately impact our industry, bioscience. The Election takes place on November 6, 2018. We encourage yo...

Learn More

Weekly Policy Update: Bills Banning Pharmacy Gag Clauses

Last week President Trump signed two bills (Patient Right to Know Drug Prices Act and Know the Lowest Price Act) into law that ban gag clauses that were called for in the American Patients First bluep...

Learn More

Colorado BioScience Association to Honor Leading Companies and Life Science Pioneers at Awards Dinner

ArcherDX, MiRagen, Biodesix Named Finalists for Company of the Year Award; Double Helix, Impressio and Inscripta Nominated for Rising Star Award DENVER – Leaders of Colorado’s bioscience sector gather...

Learn More

Weekly Policy Update: Bioscience in Recent National and International News

A quick recap of bioscience in recent national and international news. President Trump recently signed a bill prohibiting pharmacy benefit managers from imposing “gag orders” on pharmacists that preve...

Learn More

Prima-Temp Has Acquired Kindara, a Fellow Boulder-Based Women’s Healthtech Company

Prima-Temp, a women's healthtech company, has acquired Kindara, another Boulder-based women’s healthtech company. Kindara makes an app and Bluetooth-connected thermometer to help women track their fer...

Learn More

Weekly Policy Update: Advancing Innovation in Digital Health

Over the last year, in fact, FDA Commissioner Scott Gottlieb has put an emphasis on speeding up the process in getting technology and medications out to the public. This is evidenced by the new Pre- C...

Learn More

Weekly Policy Update: The September Report

Today, the September Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update.

Learn More

Weekly Policy Update: Advocating for Medicare Part D

The Colorado Bioscience Association along with We Work for Health Colorado, Epilepsy Foundation, Colorado Gerontological Society, Scleroderma Foundation, Rocky Mountain Stroke Center and the Colorado...

Learn More

Colorado BioScience Association Congratulates Cetya Therapeutics, Winner of Venture Showcase

Pitch competition wrapped up CBSA’s Colorado Life Science Innovation Forum DENVER – Colorado BioScience Association named Cetya Therapeutics the winner of its venture showcase at the Colorado Life Sci...

Learn More

Weekly Policy Update: Dianne Primavera and Lang Sias Address the Colorado Life Science Innovation Forum

The Colorado Life Science Innovation Forum is filling the Westin Westminster with interesting speakers, enlightening panelists, and Colorado’s two Lieutenant Governor candidates throughout the day tod...

Learn More

Colorado BioScience Association Welcomes Major Party Gubernatorial Running Mates to Colorado Life Science Innovation Forum on Friday

Dianne Primavera and Lang Sias to share their views on the economic outlook for the state’s bioscience industry DENVER – The Colorado Life Science Innovation Forum, the state’s largest gathering of bi...

Learn More

Weekly Policy update: Lieutenant Governor Candidates At The Colorado Life Science Innovation Forum and The State of Medicare

Colorado Life Science Innovation Forum – Keynote Featuring Remarks by Gubernatorial Running Mates Join CBSA on September 14th at the Colorado Life Science Innovation Forum.Our keynote lunch speakers i...

Learn More

Weekly Policy Update: A Month In Policy and Bioscience In the News

Today, the August Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update. BIOSCIENCE IN THE NEWS  Energy and Commerce Ne...

Learn More

CBSA Forum Highlights Global Impact of Colorado’s Life Science Innovators

Colorado Life Science Innovation Forum brings national thought leaders and Colorado executives together DENVER – Colorado BioScience Association (CBSA) hosts the state’s largest gathering of bioscienc...

Learn More

Weekly Policy Update: The FDA’s Initiatives For Medical Devices and the Upcoming Gubernatorial Candidate Forum

FDA releases three important initiatives for medical device development, innovation and safety The FDA announced it is taking steps to advance innovation and surveillance for medical devices through t...

Learn More

Weekly Policy Update: FDA Releases New Draft Guidance and the Midwest BIO CSBA Retreat

FDA Releases New Draft Guidance to advance and modernize oncology drug trials In the FDA’s ongoing effort to modernize and create a more efficient approval process, last Friday the FDA released their...

Learn More

Weekly Policy Update: FDA Funding and Other News

FDA Receives Funding in Senate Passed Appropriations Bill Last week the U.S. Senate overwhelmingly passed a $154.2 billion spending bill that includes more than $3 billion for the FDA. When industry f...

Learn More

Weekly Policy Update: Medical Device Tax and Colorado State Budget

  Scott Larson, VP, Legal and General Counsel, Terumo BCT; Jenna Hutchins, Territory Manager, ResMed; Congresswoman Dianna Degette; April Giles, President, CBSA; Jonathan Toronto, Vice President,...

Learn More

Weekly Policy Update: House Repeals Medical Device Tax

On behalf of Colorado BioScience Association thank you for your efforts to secure a yes vote on H.R. 184 - Protect Medical Innovation Act of 2017. We appreciate the time you took to advocate to your r...

Learn More

Weekly Policy Update: Full Repeal of the Medical Device Tax Advocacy

This has been another week with persistent advocacy for full repeal of the Medical device tax in standalone legislation. A permanent repeal of the medical device excise tax remains a top priority for...

Learn More

Colorado BioScience Association Announces Departure of President & CEO, April Giles

Board of Directors to Begin National Search for Replacement DENVER – Colorado BioScience Association (CBSA) announces the departure of longtime President & CEO April Giles. She served CBSA for mor...

Learn More

Weekly Policy Update: Medical Device Tax Advocacy and the CACI Legislative Candidate Interviews

CBSA continues to advocate for a full repeal of the Medical device tax in standalone legislation. A permanent repeal of the tax remains a top priority for CBSA and Colorado's medtech innovators. While...

Learn More

Weekly Policy Update: Meeting with Congresswoman Degette

This week Colorado BioScience Association along with AdvaMed, our Board Chair Scott Larson at Terumo BCT, Zimmer Biomet and ResMed met with Congresswoman DeGette. The meeting offered a great opportuni...

Learn More

Weekly Policy Update: Primary Elections, Congratulating Sen. Gardner, and Drug Pricing

2018 COLORADO PRIMARY ELECTION With the anticipated Colorado Primary Election this week, we learned the long-awaited results of who would be our top two democratic and republican candidates for Govern...

Learn More

Weekly Policy Update: FDA Releases Important Guidances

The FDA recently announced the release of important guidances, “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities–Questions and Answers,” and “Medical...

Learn More

Weekly Policy Update: Drug Pricing News

This week HHS Secretary Alex Azar appeared in front of the Senate Health, Education, Labor and Pensions Committee for a hearing on drug pricing. Secretary Azar’s prepared testimony in large part summa...

Learn More

Colorado BioScience Association Highlights Innovative Spirit, Collaborative Culture in Colorado

Annual Bioscience Colorado Magazine Profiles Leaders, Incubators and Ecosystems Colorado BioScience Association (CBSA) launched the new issue of its annual magazine, Colorado Bioscience: Igniting the...

Learn More

Weekly Policy Update: BIO International Convention and Voter Registration

This week CBSA President and CEO April Giles and Vice President Jennifer Jones returned from the 2018 BIO International Convention in Boston, Massachusetts. This annual trip is a great opportunity to...

Learn More

Weekly Policy Update: BIO International Convention and Voter Registration

POLICY UPDATES Yesterday the May Focus newsletter was published for a more detailed look at policy, and other issues, please read Jennifer’s monthly policy update in May’s Focus newsletter. 2018 BIO I...

Learn More

Weekly Policy Update: The Colorado Experience, Tariff Advocacy, and FDA Funding News

COLORADO EXPERIENCE – BOULDER This week Jennifer Jones, Vice President of the Colorado BioScience Association, participated in the Denver Metro Chamber Leadership Foundation’s Colorado Experience two-...

Learn More

Weekly Policy Update: A Quick Review of President Trump’s Prescription Medication Plan

Last Friday President Trump unveiled his administration’s plan to help make prescription drugs more affordable for patients. The blueprint called “American Patients First" builds on the president's 20...

Learn More

Coming Together as a Community

Collaborating on True Transparency to Benefit Patients Our state’s bioscience innovators work to create wearable devices to help make us healthier, develop drugs that could save a loved one from cance...

Learn More

Weekly Policy Update: Industry Defeats Harmful Transparency Measures at the Capitol

CBSA had a busy legislative session advocating on behalf the industry against transparency measures that stood to stifle bioscience innovation in Colorado and failed to provide the relief patients nee...

Learn More

Making a Difference for Patients

Meet the Colorado Leaders Developing Breakthrough Cures and Treatments Colorado’s researchers, innovators and entrepreneurs work to develop breakthroughs start locally and impact globally. Our sector’...

Learn More

Weekly Policy Update: HB-1358 Dies in Committee and Ongoing Transparency Advocacy

Advocating at the Capitol Today, April Giles, CBSA president & CEO testified in the House Health, Insurance, & Environment committee in opposition to HB18-1358 - Health Care Charges Billing Re...

Learn More

Prescription Drugs: Just the Facts

As the Colorado State Legislature considers House Bill 18-1260, Drug Price Transparency, a lot of claims and opinions are circulating in our state about the drivers of health care costs. Prescription...

Learn More

Weekly Policy Update: Action on Two Bills and Advocacy in DC

UNDER THE GOLD DOME This week, HB18-1135: Extend Advanced Industry Export Acceleration Program passed the Colorado House of Representatives and next week it moves to the Senate. This bill extends the...

Learn More

Colorado BioScience Association Names New Board Members

Leaders represent CereScan, Ocugen, Prevacept Infection Control, Sharklet and Zimmer Biomet DENVER – April 23, 2018 – Colorado BioScience Association (CBSA) announces new members elected to its board...

Learn More

Driving Down Drug Costs

Three Solutions to Help Patients and Support Innovators Current proposals under consideration at the Colorado State Legislature propose a simple fix for a complex issue. We agree, patients and their f...

Learn More

Weekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...

Learn More

Weekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!

Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...

Learn More

Understanding Bills at the Legislature

Where Do Patients Fit In? Colorado families need access to medicines and health care at affordable prices. That’s why Colorado BioScience Association supports True Transparency. This means considering...

Learn More

Weekly Policy Update: Colorado Budget and Forecast, plus a True Transparency update

CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colo...

Learn More

How do drug companies determine prices?

The Value of Innovation When you stop in to the pharmacy to pick up a prescription, you may wonder how manufacturers determine the price you pay. You may think the drug maker maintains full control ov...

Learn More

Weekly Policy Update: Advocacy Around Drug Transparency Issues, an Opportunity To Be Heard By the Next Governor, and the Omnibus Spending Bill

This week CBSA testified in opposition to House Bill 1009, Diabetes Drug Pricing Transparency Act 2018. The bill was heard in the House Health, Insurance and Environment Committee and passed on a part...

Learn More

What are Pharmacy Benefit Managers?

PBMs Largely Determine How Much Your Medicines Cost With public policy debate at Colorado’s State Capitol focused on prescription drug price transparency, it’s critical for our decision makers and the...

Learn More

Weekly Policy Update: Continuing the Transparency Advocacy and a Business Guide for the Governor

CBSA Continues to Advocate in Opposition to House Bill 1260, Prescription Drug Price Transparency As reported last week, House Bill 1260, Prescription Drug Price Transparency passed on a party line vo...

Learn More

Understanding the Costs of Your Rx

Who Determines What You Pay for Prescription Medicines? When you visit your pharmacy counter to pick up a prescription, do you know who determines the final cost you pay? Many people think it’s one co...

Learn More

Weekly Policy Update: Prescription Drug Price Transparency

Transparency at the Colorado State Capitol This week CBSA testified in opposition to House Bill 1260, Prescription Drug Price Transparency. The bill was heard in the House Health, Insurance and Enviro...

Learn More

How Do Innovative Medicines Save Lives?

Transforming How We Treat and Cure Diseases We support true transparency, which means working together to provide patients access to affordable medicines. While a few bad actors make headlines, millio...

Learn More

Weekly Policy Update: House Bill 1260 Prescription Drug Transparency, plus the Advamed Fly-In in Washington, D.C.

Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, Ho...

Learn More

What is True Transparency?

Working Together to Provide Access to Affordable Medicines It’s time to start a community conversation about prescription medicines and the out-of-pocket costs for patients. Several bills under consid...

Learn More

Weekly Policy Update: Positions on three bills, true transparency, and a visit to D.C.

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week and we continue to evaluate and make recommendations on legislation being introduced. Outlined below a...

Learn More

Weekly Policy Update: True Transparency and Medicare Stakeholder Input

CBSA promotes the interests of more than 725 bioscience companies and their 30,000 employees. We work every day to create an innovation-friendly business environment ensuring that as an industry we de...

Learn More

Colorado BioScience Association highlights state’s life-saving medical breakthroughs for lawmakers

Annual event brings health care innovators to share successes with legislators at the Capitol DENVER – Colorado BioScience Association (CBSA) brings life science innovators to meet lawmakers and highl...

Learn More

Weekly Policy Update: Colorado BioScience Association Highlights State's Life-Saving Medical Breakthroughs for Lawmakers

This week we had a successful CBSA Day at the Capitol. At the event we heard from Lieutenant Governor Donna Lynne on her top priorities, outlook on the opioid and substance abuse task force and the fu...

Learn More

Friday Policy Updates 2/2/2018

As things continue to be active and heat up over at the Colorado State Capitol, this week the Colorado BioScience Association took formal positions on three bills, while continuing to evaluate and mak...

Learn More

Friday Policy Updates 1/26/2018

UNDER THE DOME The CBSA team will be busy this legislative session working on bills that stand to have a negative impact on our industry, with an anticipated 7 healthcare transparency bills aimed at l...

Learn More

Colorado BioScience Association Highlights Medtech Disruption

Annual Medical Device Symposium discusses industry growth, innovation and federal policy outlook DENVER – On Jan. 30, 2018, the Colorado BioScience Association (CBSA) will host more than 80 medtech le...

Learn More

Colorado BioScience Association Applauds Suspension of the Medical Device Tax and Reauthorization of CHIP

  Congress delays medical device tax for two years Last night, the President signed a continuing resolution (CR) package, which includes a two-year suspension of the device tax retroactive to Dec...

Learn More

Friday Policy Update 1/19/2018

Another week goes by and we continue to strongly advocate for the repeal of the medical device excise tax. This week in DC, the House passed the continuing resolution (CR) to fund the government until...

Learn More

Millennials: Training Talent

State-Funded Program Connects Interns to Bioscience Careers Colorado’s commitment to growing a strong bioscience workforce begins with training up-and-coming talent. A state-funded program focused on...

Learn More

Friday Policy Updates 1/12/2018

UNDER THE GOLD DOME – THE 71ST GENERAL ASSEMBLY The 2018 Colorado Legislative session started this week and kicked off with several industry related health care bills. The CBSA team is already hard at...

Learn More

miRagen: Comprehensive, microRNA Targeted Therapies

Tiny Molecules Modulate Cellular Processes and Can Re-Program Cells Involved in Disease Bill Marshall was in Vienna, Austria, when he got the news. A prominent researcher had, for the first time, foun...

Learn More

Inocucor Raises $9.5 Million in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million

Inocucor Raises $9.5 Million USD ($12.1 Million CAD) in Series B Second Close Led by Pontifax AgTech, Raising Total Proceeds of Series B Financing to $38.5 Million USD ($50.9 Million CAD) Ben Belldegr...

Learn More

Friday Policy Updates – 1/5/2018

Under the Gold Dome – The 71st General Assembly The 2018 Colorado Legislative session begins next Wednesday, January 10th! The CBSA team will be busy advocating on behalf of the Colorado Bioscience in...

Learn More

Millennials in Colorado

Expanding our Workforce, Inspiring Our Companies Colorado boasts the fastest-growing Millennial population in the United States. This large demographic group is generally recognized as Americans born...

Learn More

At the Center of Everything

Our Location Gives BioScience Companies an Advantage Many factors contribute to Colorado’s reputation as an exceptional place to start, grow, commercialize or relocate a life science business. Our col...

Learn More

2017 Breaks Bioscience Records

$1.2 Billion Year Doubles Amount Raised in 2016 Colorado’s life science companies raised a record $1.2 billion in 2017, doubling the funds raised in the previous year. The funding came through venture...

Learn More

Sharklet Moves Out of the Startup Scene

Company Readies for Global Commercialization Sharklet has turned a corner. For the last 10 years, the startup company has worked to develop the chemical-free, micropatterned coating it pioneered to no...

Learn More

Regenerative Medicine in Colorado

How Researchers and Entrepreneurs are Advancing Human and Animal Health From treating painful skin conditions in children with IPS cells to using stem cells to improve quality of life for injured peop...

Learn More

Ready for Retirees

How the Sector is Preparing for the State’s Shifting Demographics Colorado consistently ranks as a top destination for retirees. With Baby Boomers reaching retirement age at the rate of 10,000 per day...

Learn More

TranS1: Innovative Products and Partnerships

Supporting Spine Surgery’s Invention Engine Minimally invasive spine surgery sounds like an oxymoron. But that’s precisely the goal at TranS1, headquartered in a restored Victorian home in Denver’s hi...

Learn More

Champions for Bioscience

Accelerating Industry Success through Advocacy The CBSA team leads advocacy efforts on behalf of the industry and our members. We work every day to create an innovation-friendly business environment....

Learn More

‘It’s All About the Kids’

Children Inspire the Team at Silvergate Pharmaceuticals As a pharmacist managing some of the largest consumer pharmacies in the country, Frank Segrave saw a need. The majority of medications on his sh...

Learn More

Diversity Suits the C-Suite

At Biodesix, Female Executives ‘Shake Things Up’ to Drive Growth Anyone who works in bioscience knows there are few women in executive leadership roles. Although women come into the industry at the sa...

Learn More

Collaborative by Nature

A Commitment to Working Together Supports Success There’s something different about Colorado. It’s more than our beautiful natural surroundings and abundant sunshine, favorable business climate and ta...

Learn More

Smart, Hard-Working and Happy

A Talented Workforce Powers Colorado’s Bioscience Industry Bright, passionate people make Colorado the ideal place for bioscience investment. Our state attracts leading talent from around the globe an...

Learn More

AlloSource Strives to Advance Healing

Colorado-based company balances unique mission with medical innovation AlloSource® began with a simple principle: to transform tragedy into possibility. Since that moment nearly 25 years ago, the comp...

Learn More

i2 Pharmaceuticals: Boulder Based, Global Reach

Pioneering Research to Solve the Drug Discovery Puzzle Creating an effective drug to treat disease is a bit of a puzzle. Researchers shape many molecular pieces and fit them together into a therapeuti...

Learn More

Quantifying Good Health in Colorado

Using Big Data to Improve Quality of Life Over the course of one person’s life, he or she may generate more than 12 terabytes of personal health data. If you were to store that information, it would b...

Learn More

Federal Labs in Colorado

Our State’s 33 Labs Make a $2.6 Billion Impact On any given day in Colorado, scientists at federal labs including the CDC in Fort Collins, NOAA in Boulder and NREL in Golden are studying diseases that...

Learn More

Boettcher Foundation Helps Early-Career Scientists

Funding Propels Investigators’ Research The Boettcher Foundation launched its Webb-Waring Biomedical Research Awards with the goal of helping early-career investigators advance their research to a poi...

Learn More

RxREVU Modernizes Prescription Management

Digital Health Platform Informs Prescribing Decisions In the center of Denver’s construction chorus—a sign of the city’s recent economic boom—CEO Carm Huntress, and his team at RxRevu have their own r...

Learn More

Precision Medicine in 3D

Printing the Future of Medicine Precision medicine often happens invisibly, in the nuclei of cells, in the dances of proteins, in the bowels of sequencers, in the processing cores of computer servers....

Learn More

8TH FOR DEVICE AND DIAGNOSTICS EMPLOYMENT

COMPANIES HIGHLIGHT THE INNOVATION HAPPENING HERE From global manufacturing powerhouses to inventive startups seeking to transform patient care, hundreds of medical device companies call Colorado home...

Learn More

SomaLogic’s Team Unlocks the Potential of Proteins

  Meet the Leaders Working to Develop a Breakthrough in Precision Medicine Sheri Wilcox has no regrets. As a post-doctoral research fellow in 2000, Wilcox was living in Michigan and on the verge...

Learn More

MBio Diagnostics to Commercialize Portable Lab Device

Boulder Company Uses LightDeck Technology for Mobile Disease Detection Chris Myatt knew he was on to something. At a conference in 2005, he met a scientist with a simple handheld prototype designed to...

Learn More

Why Choose Colorado?

What makes Colorado an ideal state for bioscience? Our state’s 300 days of sunshine a year and educated workforce appeal to homegrown companies and those looking to relocate. Our top five list, part o...

Learn More

Colorado Funds Bioscience Breakthroughs

Colorado promotes growth and sustainability for the state’s nine identified Advanced Industries, which make up 30% of the Centennial state’s economy, through a state-led Advanced Industry (AI) Acceler...

Learn More

Colorado BioScience Association Recognizes 2017 Boettcher Investigators

DENVER, June 13, 2017 — The Colorado BioScience Association on Tuesday commended the newest class of Boettcher Investigators and expressed its gratitude to the Boettcher Foundation for its continued s...

Learn More

Securisyn Medical Awarded Fourth Air Force Contract for Innovation

HIGHLANDS RANCH – November 12, 2019 – Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, announced today that the United States Air Force (US...

Learn More

AMPIO PROVIDES UPDATE ON CONTINUED PROGRESS OF AP-013 PHASE III CLINICAL TRIAL AND MANUFACTURING FACILITY

ENGLEWOOD, Colo., October 10, 2019, /PRNewswire/ — Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) a development stage biopharmaceutical company, executing a Special Protocol Assessment (S...

Learn More

Biodesix Appoints Scott Hutton as Chief Executive Officer

Former CEO David Brunel to Serve as Chairman of the Board of Directors BOULDER, Colo., November 4, 2019 -- Biodesix, Inc., the leader in lung cancer diagnostic solutions, today announced tha...

Learn More

IM Therapeutics Is Developing A Novel Targeted Therapy Pipeline in Autoimmune Disease

Type 1 Diabetes Therapy Being Readied for Clinical Trials; Celiac Disease in Drug Development Autoimmune diseases affect about 4% of the world’s population and comprise over 80 disorders, many of whic...

Learn More

SomaLogic significantly expands key strategic collaboration with Novartis

Ten-year agreement with Novartis demonstrates broad and deep commitment to accelerating disease and therapeutic-specific insights based on proprietary proteomic technology Boulder, Colo., USA — SomaLo...

Learn More

Regulatory Affairs Professionals Society (RAPS) Welcomes New RAPS Colorado Chapter

Rockville, MD, USA, Oct. 17, 2019 (GLOBE NEWSWIRE)  The Regulatory Affairs Professionals Society (RAPS) announced the official launch of the RAPS Colorado Chapter. The group first began as a RAPS...

Learn More

Securisyn Medical Receives FDA 510(k) Clearance for its SolidAIRity™ III Airway Stabilization System

HIGHLANDS RANCH – October 9, 2019 – Securisyn Medical, LLC, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (“FDA”) to market its SolidAIRity™ III Airw...

Learn More

IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures

IM Therapeutics Raises $10 Million Financing Co-Led by JDRF T1D Fund and Morningside Ventures Funding will Advance Lead Drug in Type 1 Diabetes and Develop HLA-Targeted Therapeutic Platform in Autoimm...

Learn More

AmideBio Awarded SBIR Phase II Grant to Further Development of its Novel Glucagons for the Treatment of Hyperinsulinism

BOULDER, CO, September 30, 2019 – AmideBio, LLC, a privately held biopharmaceutical company, announced today that it has received $1.56M in funding through a Phase II Small Business Innovation Researc...

Learn More

GREFFEX, Inc. Awarded $18.7 Million Contract with NIH to Develop a Plug-and-Play Technology Platform to Expedite Production of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

GREFFEX, Inc. (Aurora, CO), a Fitzsimons Innovation Community company, is a transformative leader in genetic engineering. The company was recently awarded an $18.7 million contract with the National I...

Learn More

Weekly Policy Update: CBSA Submits Comment Letter to CMS Advocating for Patient Access to Timely Precision Diagnostic Information

In July the Centers for Medicare and Medicaid Services (CMS) issued the CY 2020 Hospital Outpatient Prospective Payment System (HOPPS) Proposed Rule, which included concerning proposed revisions to th...

Learn More

Boulder Based Edgewise Therapeutics Closes $50 Million Series B Financing

Financing to Support Advancing Company’s Lead Product Candidate for Muscular Dystrophy- Boulder, Colo., (September 17, 2019) – Edgewise Therapeutics, a preclinical company developing small molecule th...

Learn More

Nymbl Science Releases Their August Update

Below please find an overview of our progress for the month of August: • We continue to move forward towards closing out our round. We have about $235k remaining with 4 angel pitches lined up in the n...

Learn More

Denver Business Journal Highlights Colorado’s Life Sciences Ecosystem and Our Leadership In Gene Editing

Gene editing is becoming an increasingly common remedy for a variety of ailments, and Boulder area bioscience companies are leading those advancements. Building on research and technology originating...

Learn More

SomaLogic launches its first SomaSignal™ tests in select medical practices

Novel tests based on large-scale protein measurements will first offer personal and precise information about an individual’s cardiometabolic health status and trajectory Boulder, Colo., September 4,...

Learn More

Securisyn Medical Partners with Leading Medical Device Design and Development Firm, Meddux

HIGHLANDS RANCH, Colo., August 12, 2019 — Securisyn Medical, LLC, dedicated to inspiring the world to collaborate to make airway management safer, has announced a new partnership with Meddux™ Developm...

Learn More

Allosource Celebrates 25 Years Of Doing More With Life

Milestone highlights organization’s growth into one of the largest tissue banks in the U.S. Centennial, Colo. — August 9, 2019 — AlloSource®, an organization dedicated to advancing the science and use...

Learn More

Zoetis Establishes Research Lab At CSU To Explore Immunotherapies For Livestock

Zoetis, the world’s leading animal health company, has signed an agreement with Colorado State University to establish a research lab at CSU that will explore the livestock immune system and target ne...

Learn More

Agilent Announces Purchase of Boulder Facility

Agilent Technologies has announced it is purchasing the building in Boulder where they have been manufacturing therapeutic oligonucleotides (“oligos") for over a decade. This $12 million purchase, alo...

Learn More

Silvergate Pharmaceuticals Merges With CutisPharma To Serve Patients On Opposite Ends of the Spectrum

Silvergate Pharmaceuticals produces pediatric medications, while CutisPharma has served the senior population. They’re bringing their companies together to form Azurity Pharmaceuticals. While it might...

Learn More

Cerapedics Announces Expansion of Colorado Headquarters

WESTMINSTER, Colo., July 8, 2019 /PRNewswire/ -- Cerapedics, a private ortho-biologics company, today announced the expansion of the company's headquarters located in the Denver metropolitan area. Ove...

Learn More

Seven Researchers Named Boettcher Investigators

Newest Class Marks 10th Group Selected Under Webb-Waring Program Back row (l-r): Kara Mould, M. Cecilia Caino, Seonil Kim Front row (l-r): Neelanjan Mukherjee, Robert Dietz, Tara Cepon Robins Not pict...

Learn More

ArcherDX Announces Close of $60M Financing to Advance Companion Diagnostic and Minimal Residual Disease Monitoring Product Portfolio

BOULDER, Colo., May, 15, 2019 /PRNEWSWIRE/-- ArcherDX, Inc., a molecular technology company dedicated to developing breakthrough solutions that advance the application of personalized genomic medicine...

Learn More

Prima-Temp Announces New Leadership, Investment, and CE Mark Certification

BOULDER, Colo., May 3, 2019 /PRNewswire/ -- Boulder, Colorado based Prima-Temp, Inc. a developer and manufacturer of AI-assisted fertility management products, announced today that in March, it raised...

Learn More

AdvaMed President and CEO Releases Statement On the House Bill To Repeal the Medical Device Tax

WASHINGTON, D.C. – Scott Whitaker, president and CEO of the Advanced Medical Technology Association (AdvaMed), issued the following statement on introduction of bipartisan legislation (H.R. 2207) in t...

Learn More

Inscripta Completes $20M Expansion of Series C Financing, Increasing Total Round to $105.5M

Inscripta, a leading gene editing technology company, today announced that it has increased its previously announced Series C financing with an additional $20 million from existing investors. The new...

Learn More

Colorado BioScience Association Applauds Expansion by Novartis Company AveXis to Longmont

April 1, 2019 Background: AveXis, a Novartis company, announced the growth of its global advanced gene therapy manufacturing capacity with the acquisition of an advanced biologics therapy facility in...

Learn More

David Perez Is Leaving Terumo BCT, But He'll Still Be Active In The Bioscience Community

Terumo BCT's CEO David Perez may be retiring, but he isn't leaving the Colorado bioscience community. He sat down with the Denver Business Journal’s James Rodriguez to discuss his successes at Terumo...

Learn More

Sapphire Technology Completes a Nationwide Distribution Agreement With Burkhart Dental Supply

Denver-based dental instrument company, Sapphire Technology, recently completed a nationwide distribution agreement with Burkhart Dental Supply (Tacoma, WA). Burkhart will soon market and sell Sapphir...

Learn More

New Office Location Helps Packaging Compliance Labs Accelerate Growth In Healthcare Packaging

Packaging Compliance Labs, a top medical device and pharmaceutical packaging engineering and validation firm, recently opened a new office in the heart of downtown Denver, Colorado, to accommodate rap...

Learn More

Colorado BioScience Association Congratulates Researchers Honored with Boettcher Foundation Webb-Waring Awards

Seven biomedical researchers at Colorado’s top research institutions have been selected to receive $1.41 million in total funding from the Boettcher Foundation’s Webb-Waring Biomedical Research Awards...

Learn More

National Bioscience Industry Report Shows $2T Economic Impact, Accelerated Venture Capital Investment & Job Growth

A study released today at the BIO International Convention shows that the U.S. bioscience industry has reached $2 trillion in annual economic impact while maintaining accelerated venture capital inves...

Learn More

Just-Released Economic Data Finds Improving Education in Colorado Would Generate Billions for the Economy

New statewide polling shows education is a top tier issue for Colorado voters and employers, alignment on improvement strategies May 15, 2018 – Denver – If Colorado schools were the best in the nation...

Learn More

Gates Biomanufacturing Facility readies first shipment of clinical trial cancer treatments

Groundbreaking moment represents years of planning, training and biomedical expertise The Gates Biomanufacturing Facility at the University of Colorado Anschutz Medical Campus has passed an important...

Learn More

Articulus Bio to Present at 6th Annual Venture Summit West Investor Conference

Articulus Bio, LLC, a development-stage orthopedic medical device platform focused on total joint replacement, today announced that Adam B. Rubenstein, Chief Executive Officer, will present at the 6th...

Learn More

CSU’s BioMARC Wins HIV Vaccine Manufacturing Project

BioMARC, a non-profit biologics contract development and manufacturing organization (CDMO) owned and operated by Colorado State University (CSU), has won a large new contract with Sumagen Co., Ltd, a...

Learn More

Cleanroom World Opens Training Center

  Colorado-Based Controlled Environment Supplier Provides Fully-Operational Cleanroom Training Center for Industry Specific Needs Cleanroom World has announced the opening of its on-site training...

Learn More

BIO Business Solutions Introduces Cyber Insurance Coverages through Aon and Chubb

  As a leading life sciences firm, it’s your mission to drive innovation and ensure your people and assets are protected. The pervasiveness of Cyber in day-to-day business operations introduces s...

Learn More

Vivaldi Biosciences’ Phase 2 Influenza Vaccine Shows Broad Cross-Protection and Superiority in Nonclinical Study

 FORT COLLINS, Colorado – February 12, 2018 − Vivaldi Biosciences, based at the Research Innovation Center at Colorado State University and Vienna, Austria, today announced that its deltaFLU infl...

Learn More

RxRevu Unveils New SwiftRx® Platform at 36th Annual J.P.Morgan Healthcare Conference

RxRevu, the industry leader in Prescription Decision Support, will unveil its new SwiftRx® platform while attending the 36th Annual J.P.Morgan Healthcare Conference on January 8th in San Francisco, CA...

Learn More

ARTICULUS BIO TO PRESENT AT 10TH ANNUAL BIOTECH SHOWCASE CONFERENCE DURING JP MORGAN HEALTHCARE WEEK

Articulus Bio, LLC, a development-stage orthopedic medical device platform focused on total joint replacement, today announced that Adam B. Rubenstein, Chief Executive Officer, will present at the 10t...

Learn More